WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 25, 2009, 29(8):2414-2427; doi:10.1523/JNEUROSCI.5687-08.2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joshi, P. R.
Right arrow Articles by Bamford, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joshi, P. R.
Right arrow Articles by Bamford, N. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CADMIUM COMPOUNDS
*CADMIUM, ELEMENTAL
Medline Plus Health Information
*Huntington's Disease
*Hurricanes
*Seniors' Health

 Previous Article  |  Next Article 

Neurobiology of Disease
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease

Prasad R. Joshi,1 * Nan-Ping Wu,1 * Véronique M. André,1 Damian M. Cummings,1 Carlos Cepeda,1 John A. Joyce,5 Jeffrey B. Carroll,3,4 Blair R. Leavitt,3 Michael R. Hayden,3 Michael S. Levine,1 and Nigel S. Bamford2,5,6,7,8 *

1Mental Retardation Research Center, The David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, 2Center on Human Development and Disability, University of Washington, Seattle, Washington 98105, 3Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Department of Medical Genetics and 4Department of Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4, and Departments of 5Neurology, 6Pediatrics, 7Psychology, and 8Neurobiology and Behavior, University of Washington and Seattle Children's Hospital, Seattle, Washington 98105

Correspondence should be addressed to Dr. Nigel S. Bamford, University of Washington, Department of Neurology, Box 356465, RR650, 1955 NE Pacific Street, Seattle, WA 98105. Email: bamford{at}u.washington.edu

Huntington disease is a genetic neurodegenerative disorder that produces motor, neuropsychiatric, and cognitive deficits and is caused by an abnormal expansion of the CAG tract in the huntingtin (htt) gene. In humans, mutated htt induces a preferential loss of medium spiny neurons in the striatum and, to a lesser extent, a loss of cortical neurons as the disease progresses. The mechanisms causing these degenerative changes remain unclear, but they may involve synaptic dysregulation. We examined the activity of the corticostriatal pathway using a combination of electrophysiological and optical imaging approaches in brain slices and acutely dissociated neurons from the YAC128 mouse model of Huntington disease. The results demonstrated biphasic age-dependent changes in corticostriatal function. At 1 month, before the behavioral phenotype develops, synaptic currents and glutamate release were increased. At 7 and 12 months, after the development of the behavioral phenotype, evoked synaptic currents were reduced. Glutamate release was decreased by 7 months and was markedly reduced by 12 months. These age-dependent alterations in corticostriatal activity were paralleled by a decrease in dopamine D2 receptor modulation of the presynaptic terminal. Together, these findings point to dynamic alterations at the corticostriatal pathway and emphasize that therapies directed toward preventing or alleviating symptoms need to be specifically designed depending on the stage of disease progression.

Key words: Huntington; striatum; cortex; excitability; glutamate; AMPA receptor; dopamine; dopamine receptor; neurotoxicity; corticostriatal; excitotoxicity


Received Nov. 28, 2008; revised Jan. 6, 2009; accepted Jan. 23, 2009.

Correspondence should be addressed to Dr. Nigel S. Bamford, University of Washington, Department of Neurology, Box 356465, RR650, 1955 NE Pacific Street, Seattle, WA 98105. Email: bamford{at}u.washington.edu






-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-